![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Efficacy of once-weekly MK-8591 in SIV infected rhesus macaques
|
|
|
Reported by Jules Levin
17th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy; June 8-10, 2016; Washington, DC
J.A. Grobler1, D. Nicoll-Griffith, M.-T. Lai, K. Fillgrove, A. Lindauer, M.L. Rizk, D.J. Hazuda
1Merck Research Labs, Antiviral Research, West Point, USA
Long-Acting Oral and Parenteral Dosing of MK-8591 for HIV Treatment or Prophylaxis......http://www.natap.org/2016/CROI/croi_14.htm
A Single Monotherapy Dose of MK-8591,a Novel NRTI, Suppresses HIV for Ten Days......http://www.natap.org/2016/CROI/croi_09.htm
![Clin1](../images/061716/061716-7/Clin1.gif)
![Clin2](../images/061716/061716-7/Clin2.gif)
![Clin3](../images/061716/061716-7/Clin3.gif)
![Clin4](../images/061716/061716-7/Clin4.gif)
![Clin5](../images/061716/061716-7/Clin5.gif)
![Clin6](../images/061716/061716-7/Clin6.gif)
![Clin7](../images/061716/061716-7/Clin7.gif)
![Clin8](../images/061716/061716-7/Clin8.gif)
![Clin9](../images/061716/061716-7/Clin9.gif)
![Clin10](../images/061716/061716-7/Clin10.gif)
![Clin11](../images/061716/061716-7/Clin11.gif)
![Clin12](../images/061716/061716-7/Clin12.gif)
![Clin13](../images/061716/061716-7/Clin13.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|